The amygdala is required for processing and expressing emotional information, and its dysregulation is associated with emotional dysfunction 8, 9 . The amygdala is a prime target for treating anxiety-related disorders because it couples sensory stimuli and outputs to effector regions involved in behavioral responses 10 . The amygdala contains several subnuclei with phenotypically distinct neuronal populations, each of which potentially plays a unique role in processing stress and other fear-related stimuli 8, 11 . The basolateral nucleus of the amygdala (BLA) is highly enriched in glutamatergic principal neurons and is required for associative learning. The central nucleus of the amygdala (CeA) primarily consists of GABAergic medium spiny neurons and controls the processing and expression of emotion. The CeA constitutes the major outputs of the amygdala and mediates autonomic and behavioral correlates of fear and anxiety 12, 13 . Growing evidence also shows that metabotropic receptor signaling mediates the cross talk and neural circuitry-dependent actions of neuropeptides and neurotransmitters that play modulatory and integrative roles in the cellular and molecular basis of emotion 14, 15 . Although IP 3 K-A is abundantly expressed, its role in the amygdala is still elusive. Given the findings on the IP 3 K-A knockout (KO) mice in hippocampus-dependent learning, we hypothesize that amygdala IP 3 K-A may play a role in the association between environment and emotion. Thus, we characterized molecular signatures of the amygdala in IP 3 K-A KO mice and examined the functional consequences of IP 3 K-A KO through electrophysiology and behavioral assessments.
Results

Amygdala expression of IP 3 K-A.
In adult mice, IP 3 K-A is expressed in the forebrain, and our preliminary results indicated that the amygdala had abundant expression of IP 3 K-A gene transcripts 2, 3 . We found that IP 3 K-A protein expression is highly enriched in the amygdala; immunoreactivity is particularly strong in the CeA and BLA (Fig. 1a) . To identify cells expressing IP 3 K-A, we examined co-localization of IP 3 K-A with markers of specific cell types using immunohistochemistry. IP 3 K-A colocalized with NeuN but was barely detectable in glial fibrillary acidic protein (GFAP)-positive cells, indicating that IP 3 K-A is primarily expressed in neurons rather than glia in the amygdala (Fig. 1a) . In the CeA, IP 3 K-A primarily colocalized with GAD67-positive GABAergic interneurons, whereas most IP 3 K-A in the BLA was in CAMKIIα -positive excitatory pyramidal neurons (Fig. 1b) . To determine whether IP 3 K-A regulates neuronal activity, we compared amygdala c-Fos expression in WT and KO mice. C-Fos expression was reduced in the BLA and CeA of KO mice (Fig. 1c) ; therefore, IP 3 K-A may regulate amygdala function by affecting the excitatory and inhibitory components of the intra-amygdaloid circuits.
Genome-wide amygdala mRNA expression in IP 3 K-A KO mice. Because reduced c-Fos expression is associated with changes in amygdala gene expression, we compared genome-wide mRNA expression from amygdala tissue of WT and KO mice using microarrays. We identified 265 differentially expressed gene (DEG) transcripts and categorized the DEG sets by canonical pathway and biological function/disease using Ingenuity Pathway Analysis (IPA) software. Enrichment analyses of DEGs revealed that important signaling pathways could be significantly altered by loss of IP 3 K-A, including chemokine receptor signaling, MAPK, GPCR (cyclic adenosine monophosphate [cAMP] and PLC-mediated signaling), and Rho family GTPase signaling pathways (Fig. 2a) . These pathways are downstream of metabotropic receptor-initiated signals mediating various neurotransmitters, neuropeptides, and growth factors. Key signal transduction pathways (including MAPK and GPCR pathways) were biased toward inhibition (Activation Z-scores: MAPK/ERK, − 2.120; MAPK/p38, − 2.380; cAMP-mediated signaling, − 1.633; PLC-mediated signaling, − 1.516). When examining annotation of related biological function/ disease, we found significant alterations in GPCR-and calcium-related signaling pathways that corresponded with the identified functions of IP 3 Ks in the canonical pathway (Fig. 2b) . Importantly, a subset of genes related to anxiety-like behaviors and psychiatric illness (e.g., post-traumatic stress disorder [PTSD] and addiction) was significantly enriched in our DEG set. Representative DEGs from the analyses are summarized as a heat map presentation, including PLC-and Rho GTPase-coupled signaling and fear-and anxiety-related phenotypes (Fig. 2c) .
Among 265 DEGs identified by IPA, we focused on eighteen DEGs chosen based on functional importance, extent of group-difference, and validated expression patterns by qRT-PCR (Fig. 3) . Featured genes were in one or more functional categories listed in Fig. 2 and primarily were related to fear-and anxiety-related behaviors and/or GPCR-and calcium-associated signaling pathways. For example, genes associated with emotional abnormalities and linked with GPCR signaling (Adora2a, Drd2, Pdyn, Gng7, Lcn2, and c-Fos) were significantly down-regulated in the KO amygdala (Fig. 3a) . Additionally, expression of several mRNA encoding phospholipases (Pla2g4b, Plag4e, and Pla2g5) and their interacting molecules were altered in KO mice, suggesting a potential bias of cellular events including regulation of cyclic nucleotide-, PLC/calcium-, and/or GTPase-dependent signal transduction (Fig. 3b) . Expression of several gene transcripts (Pak6, Commd7, and Ivd) was dramatically attenuated, whereas Ifna4 and Pla2g4e mRNA levels were highly increased in the KO animals. These results suggest that amygdala function-particularly control of emotional processing-may be influenced by IP 3 K-A.
Fear-and anxiety-related behavior in IP 3 K-A KO mice. The amygdala processes fear information and long-term aversive learning 9 ; therefore, we examined whether fear-related learning occurs in IP 3 K-A KO mice. For this purpose, adult male WT and KO mice were tested using contextual and auditory-cued Pavlovian fear conditioning, well-established behavioral paradigms of amygdala-dependent function. During training, the KO and WT mice freely explored the chamber without any differences in freezing behavior, indicating normal motor function in the KO mice. Although impairment in hippocampus-dependent learning were shown in the previous study 7 , IP 3 K-A KO mice had a longer freezing duration under a context-dependent test scheme ( Fig. 4a ), but showed similar freezing levels in response to conditioned stimuli in the auditory fear conditioning test (Fig. 4b) . Interestingly, IP 3 K-A KO mice exhibited a stronger freezing response than WT mice during the acquisition phase of auditory fear conditioning. Stronger freezing responses of the KO mice were found during three successive training sessions (Fig. 4c) as well as the inter-tone intervals (Fig. 4d) . It is also noteworthy that the innate fear responses of KO mice were significantly strengthened. Compared with WT mice, they showed more freezing behaviors after exposure to the synthetic predator odor (Fig. 4e) . Considering that locomotor activities of KO mice were not significantly impaired in a novel Plexiglas box (Fig. 4f) , our findings suggest that IP 3 K-A may affect innate fear-related phenotypes, rather than aversive learning processes or motor activities.
IP 3 K-A KO mice also exhibited anxious phenotypes (Fig. 4g) ; KO mice spent less time in open arms of the elevated plus maze (EPM) than control mice, indicating a higher state of anxiety. To further assess anxious phenotypes, we carried out the acoustic startle response test, a widely used index of physiological responses to intense and sudden auditory stimuli. It is well known to reflect innate fear and anxiety, although it is also influenced by general sensorimotor functions 16, 17 . During the test, KO animals displayed a more pronounced startle response to increased auditory stimuli, supporting the idea that IP 3 K-A KO animals have a higher level of innate fear and anxiety (Fig. 4h ).
Electrophysiological properties of IP 3 K-A KO mice. Expression of IP 3 K-A in the amygdala-particularly in BLA excitatory neurons and CeA GABAergic interneurons-implies that IP 3 K-A loss can affect neuronal activity in amygdala circuits. As shown in Fig. 5a , sEPSC frequency in the CeL of KO mice was significantly decreased, suggesting that excitatory inputs from LA neurons to CeA inhibitory neurons were weakened. Accordingly, sIPSC frequency in the CeM-an inhibitory output of the amygdala to the brainstem-also was attenuated (Fig. 5b) , indicating decreased feed-forward inhibition onto CeA output neurons. We found no significant differences in basic electrophysiological properties between groups, such as resting membrane potential (WT: − 66.36 ± 1.51 mV, n = 10; KO: − 66.84 ± 1.21 mV, n = 7) and input resistance (WT: 86.86 ± 9.03 MΩ, n = 10; KO: 85.46 ± 8.20 MΩ, n = 7). However, the input-output functions of CeL neurons were significantly attenuated along with a longer latency to the first spike in KO mice (Fig. 5c) . We then examined induction and maintenance of LTP in the thalamo-LA pathway, which correlates with auditory fear memory formation. We recorded evoked EPSPs in this pathway and induced LTP by applying high-frequency stimuli (6 trains of 1 sec, 
by t-test).
100 Hz stimulation; 1 min inter-train intervals). We found that LTP was not significantly different between WT and KO animals (Fig. 5d) , which confirms our finding of normal auditory cue-evoked fear responses in KO mice. 
Discussion
Our study provides the first evidence of functional IP 3 K-A expression in the amygdala and its role in regulating emotion. Genetic deletion of IP 3 K-A altered emotional behavior; the mutant mice had abnormal fear-and anxiety-related behaviors and attenuated synaptic transmission in the CeA. KO mice also exhibited altered expression of multiple amygdala genes, particularly involving metabotropic receptor signaling.
IP 3 K-A was abundantly expressed in multiple amygdaloid nuclei, including the CeA and BLA. Microarray experiments and canonical pathway analysis on DEGs also support the functional importance of IP 3 K-A in the amygdala. IP 3 K-A phosphorylates IP 3 , which is usually produced by multiple PLCs to generate the third-messenger IP 4 and terminate the initial phase response to the activation of GPCRs and receptor tyrosine kinases (RTKs) 1 . Therefore, it is important that a variety of effector genes controlling calcium homeostasis and signal transduction by cAMP, PLCs, and Rho-GTPases were significantly influenced by IP 3 K-A loss. Concomitant and biased changes in expression of these signaling molecules along with reduced c-Fos expression indicate that IP 3 K-A is required for proper responsiveness of the amygdala to extracellular stimuli. IP 3 K-A immunoreactivity was found in the GABAergic inhibitory neurons of the CeA and the CAMKIIα -positive excitatory neurons of the BLA. Previous studies only have found IP 3 K-A expressed in excitatory neuronal populations (e.g., hippocampal pyramidal neurons and cerebellar Purkinje cells) 2 . Our findings provide direct evidence that IP 3 K-A plays a role in controlling GABAergic neurons in the CeA. We found decreased c-Fos expression in excitatory and inhibitory neurons and found impaired GABAergic neuron excitability in the CeL of KO mice. Because intracellular increases in IP 3 are often coupled with increased inhibitory neuron excitability in subdivisions of the CeA 18 , we postulate that the steady-state of intracellular IP 3 function could be reduced by a feedback mechanism involving a subset of inositol phosphate phosphatases and/or by desensitization of signaling molecules mediating the action of IP 3 .
Our behavioral studies suggest that IP 3 K-A plays a role in controlling emotion. KO mice exhibited a more robust fear response to multiple aversive stimuli and showed more anxious phenotypes than WT mice (Fig. 4) . Previous studies reported defects in hippocampal LTP and hippocampus-dependent memory performance using the same mouse model 6, 7 ; therefore, increased freezing behaviors in response to the conditioned context may be due to abnormal brain function related to contextual fear memory formation. However, several lines of evidence collectively support that reinforced innate fear and anxiety, rather than the processing of fear-associated information, can have a larger impact on emotional phenotype. This evidence includes our findings on freezing responses during inter-tone intervals of fear conditioning, freezing responses to predator odor, anxious behaviors on an elevated plus maze, and potentiated acoustic startle responses. Abnormally enhanced innate fear and anxiety are features of anxiety disorders, including PTSD, generalized anxiety disorder, and panic disorder. Our bioinformatics pathway analyses also suggested behavioral alterations related to anxiety, place aversion, and PTSD. Several DEGs in this study (i.e., Adora2a, Drd2, Pdyn, Gng7, and Lcn2) are associated with onset and severity of anxiety disorders in human genetic studies 19, 20 or result in emotional abnormalities in transgenic animal models [21] [22] [23] . Interestingly, chronic social-defeat stress leading to depressive and anxious states produces changes in Adora2a, Drd2, Gng7, and Lcn2 mRNA expression in the amygdala 24 . Therefore, genetic deletion IP 3 K-A could disrupt normal amygdala gene expression crucial for controlling emotion, which would result in enhanced fear-and anxiety-related phenotypes.
Our electrophysiological findings also provide evidence of behavioral abnormalities in the KO mice. Recent studies demonstrated that the CeA is an integrative hub for innate fear and anxiety in humans and rodents 25, 26 . Neural activity in the BLA-CeA circuitry is primarily responsible for autonomic and behavioral control of fear and anxiety. Excitatory inputs from the BLA can activate GABAergic neurons in the CeL, which provide feed-forward inhibition onto inhibitory projection neurons primarily located in the CeM. GABAergic projections from the CeM to hypothalamic nuclei and the periaqueductal gray may mediate autonomic and behavioral fear-and anxiety-related responses 27 . Inhibition of BLA-CeL synapses increases anxiety-related behavior, whereas optogenetic activation of glutamatergic neurons of the BLA has anxiolytic effects 13 . We found that excitatory inputs to the CeL and inhibitory inputs to the CeM were impaired in KO mice (Fig. 5) . A disinhibition of afferent pathways from the CeM of KO mice likely underlies their enhanced fear-and anxiety-like responses to aversive stimuli. Multiple GPCR ligands play pivotal roles in integrating neural activity in amygdala circuits and the accompanying emotional states. These ligands include neuropeptides (e.g. cholecystokinin, neuropeptide Y, and corticotrophin-releasing hormone) and neurotransmitters activating their metabotropic receptors 17, 28, 29 . Subtle but persistent changes in mediators of GPCR signaling (Gng7 and regulator of G-protein signaling 2 [Rgs2]) can impact anxiety and aggressive behaviors 21, 30 , and alterations in cAMP, PLC, and Rho GTPase-mediated signaling may cause abnormal neural activity in IP 3 K-A-deficient amygdala circuitry.
In conclusion, this study demonstrates that IP 3 K-A is abundantly and functionally expressed in CeA GABAergic neurons and BLA excitatory neurons. Our molecular and electrophysiological evidence supports our findings of amygdala dysfunction and behavioral abnormalities in reinforced fear and anxiety in IP 3 K-A-deficient mice. Because IP 3 K-A primarily controls intracellular IP 3 levels and synaptic organization, IP 3 K-A may modulate neuronal excitability mediated by GPCR signaling. Intracellular signaling modulators such as IP 3 K-A are not as commonly discussed for their clinical applications as membrane receptors and their ligands; however, our findings suggest that animal models with altered IP 3 K-A may represent multiple phenotypes of human anxiety disorders. Small molecular modulators of IP 3 Ks recently have been developed, and IP 3 K dysfunction has been implicated in other human diseases such as neurodegenerative disorders, immune disorders, and cancer 31, 32 . Therefore, clarifying the impact of therapeutically modulating IP 3 K for emotional and cognitive function is critically important.
Methods
Animals and tissue preparation. Male IP 3 K-A KO mice and their wild-type (WT) littermate controls from a C57BL/6N background were used at 10 to 15 weeks old. Mice were housed in temperature (22-23 °C)-and humidity (50%)-controlled quarters under a 12-hr light/dark photoperiod (lights on at 08:00a.m.) with free access to food and water. Three-to-five male mice from different litters were housed in a cage after weaning, regardless of their genotype. Then, they were individually housed one week before all experiments. Mice were sacrificed between 02:00p.m. and 04:00p.m. Amygdala tissue was rapidly dissected from 1-mm thick slices and frozen in liquid nitrogen as described previously 33 . All procedures were carried out in accordance with the ethical guidelines of Korea University and with the approval of the Animal Care and Use Committee of Korea University.
Immunohistochemistry. Immunohistochemistry was performed as described previously 7 . Briefly, mice were perfused transcardially with 0.9% NaCl containing 25 U/mL heparin, then 4% paraformaldehyde in tris-buffered saline (pH 7.4). Brains were removed, post-fixed overnight at 4 °C in the same fixative, and cryoprotected in a series of solutions (10%, 20%, and 30% sucrose in phosphate-buffered saline [PBS]). Frozen brains were coronally cut (40 μm thick). Sections were blocked with PBS containing 5% normal goat serum and 0.2% Triton X-100 for 30 min and incubated with anti-IP 3 K-A (Santa Cruz Biotechnology, Dallas, TX), anti-NeuN, anti-GFAP, anti-CamKIIα (Invitrogen, Carlsbad, CA), anti-GAD67 (Millipore, Billerica, MA), or anti-c-Fos (Santa Cruz Biotechnology) antibodies overnight at 4 °C. After PBS washes, sections were incubated with Cy3, Cy5, or Alexa Fluor ® 488-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA) for 30 min at room temperature. After three washes, sections were mounted with aqueous mounting medium (Biomeda, Foster City, CA) and observed on an Axiovert 200 Fluorescent microscope (Zeiss, Oberkochen, Germany).
Microarray analysis. Analysis of RNA using microarray was performed as previously described 34 with minor modifications. Total RNA was extracted using RNeasy Mini kits (Qiagen, Valencia, CA) and quality was evaluated with an Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA). Three sets of pooled samples (i.e., from 6 to 8 mice per genotype from three litters) were independently prepared and analyzed. For each sample, 200 ng RNA was amplified, labeled, and analyzed using GeneChip Mouse Gene 2.0 ST arrays (Affymetrix, Santa Clara, CA) according to manufacturer's protocols. The data from microarray analyses were deposited in the Gene Expression Omnibus (GEO) database (Accession #: GSE77001). Differentially expressed genes (DEGs; more than 1.2-fold changes at p < 0.1 by Student t's test) were used to construct a dataset and analyzed using the "core analysis" function of Ingenuity Pathway Analysis TM (IPA; www.ingenuity.com; Qiagen). We used "canonical pathway analysis" and "biological functions/disease annotation" to explore affected pathways and predict alterations in amygdala function.
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Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR). For DEGs identified
in the microarray analysis, we validated alterations in expression using qRT-PCR as described previously 34 . We reverse-transcribed 500 ng RNA with MMLV reverse transcriptase (Promega, Fitchburg, WI). cDNA underwent qPCR with SYBR Green I and ROX as a passive dye (Sigma Aldrich, St. Louis, MO). TATA box-binding protein was the internal control. Primer sequences are listed in Table S1 .
Behavioral studies. Behavioral assessments were performed as described previously with modifications 33, 35 . Mice were not repeatedly used for multiple behavioral experiments.
Fear conditioning. The square type-training chamber (20 × 15 × 25 cm) had four transparent walls and a foot-shocking grid floor; here, training and context tests were performed. The tone test was performed in a 20-cm diameter × 30-cm height transparent cylindrical cage with bedding. All mice were habituated to the conditioning chamber for 2 days (10 min/day). Conditioning began with presentation of the tone (conditioned stimulus [CS] ; 30 sec at 80 dB/3000 Hz) with the foot shock (unconditioned stimulus; 0.4 mA) delivered during the last 2 sec of CS presentation. The intertrial interval lasted 30 sec. Context tests occurred 24 hr after conditioning, and tone tests occurred 48 hr after conditioning. Context memory tests occurred in the training chamber without CS for 3 min, and tone memory was measured in the transparent cylindrical cage using the same procedure but without electric shocks. During each trial, freezing (indicating fear memory) was measured by an automatic system (SmartEye ® , Göthenburg, Sweden).
Novelty-induced locomotion. Mice were individually placed into a novel Plexiglas box (40 × 40 × 30 cm) for 30 min. Locomotor activities were recorded by an overhead video camera connected to a computer with tracking software (Ethovision 3.1, Noldus, Leesburg, VA).
Innate fear response to predator odor. To examine innate fear, mice were placed in a chamber with a beaker containing 30 μl synthetic fox feces odor trimethylthiazoline (TMT, Contech Enterprises Inc., Victoria, Canada) as previously reported. TMT-evoked freezing behavior was recorded for 10 min after TMT exposure and scored as average percentage of freezing time in the last 4 min. Acoustic startle test. Acoustic startle measure is based on reflexive whole-body flinches (startle responses) following exposure to a sudden noise, as described previously 36 . Startle responses to acoustic stimuli were determined using a standard startle chamber, a soundproof apparatus with a plexiglass cylinder to hold animals and a speaker producing sound bursts. Animal motion was detected via a load cell transducer below the cylinder. Prior to testing, animals were acclimatized to the chamber for 30 min for 3 days with background white noise at 60 dB. After 5 min of habituation, mice underwent five sessions of random sound bursts from 70 dB to 120 dB in 5 dB intervals (55 trials total, 40 ms duration, 60 sec intertrial interval).
Electrophysiology. Slice preparation. Isolated whole brains were placed in ice-cold artificial cerebrospinal fluid (aCSF) containing (in mM): 175 sucrose, 20 NaCl, 3. Whole-cell patch-clamp recordings. Recordings were made using an EPC10 amplifier (HEKA Elektronik, Lambrecht, Germany). Signals were sampled at 5 kHz and filtered at 3 kHz with the Bessel filter of the amplifier. We used pipettes (resistance, 2.5-3.5 MΩ) filled with (in mM): 120 KCl (for spontaneous inhibitory postsynaptic currents [sIPSCs]) or K-gluconate (for intrinsic properties and spontaneous excitatory postsynaptic currents [sEPSCs] at the central amygdala or evoked excitatory postsynaptic potentials [eEPSPs] at the thalamo-lateral amygdala [LA]), 10 HEPES, 1 MgCl 2 , 5 NaCl, 0.2 EGTA, 3 QX314, 2 Mg-ATP, and 0.3 Na-GTP (pH 7.2 using KOH; osmolarity ~297 mmol/kg using sucrose). Neurons were voltage-clamped at -50 mV for sIPSC or − 70 mV for sEPSC. Solutions were perfused via superfusion by gravity at 1.3 to 1.5 mL/min and maintained at 32 ± 1 °C. After whole-cell configuration, series resistance was regularly monitored, and if changed by > 20%, the data were discarded. sEPSCs and sIPSCs were analyzed using MiniAnalysis software (Synaptosoft, Decatur, GA). The detection threshold was three times the RMS noise, and data were discarded if the rise time was higher than 4 ms and the decay time was greater than 10 ms. RMS noise of WT and KO mice were not different (medial CeA [CeM] sIPSC: WT, n = 9, 2.73 ± 0.20 pA; KO, n = 7, 3.07 ± 0.23 pA; unpaired t-test, p = 0.2719; lateral CeA [CeL] sEPSC: WT, n = 18, 3.02 ± 0.24 pA; KO, n = 14, 2.94 ± 0.20 pA; unpaired t-test, p = 0.7981). Peaks were selected from the part recorded at least 10 min after treatment with NBQX (10 μM) and D-APV (30 μM) for sIPSCs or picrotoxin (100 μM) for sEPSCs. Consequence 300 peaks were collected from detected peaks for further analysis. To record evoked EPSPs at the thalamo-LA pathway, the stimulation electrode was placed at the midpoint of the trunk between the internal capsule and the medial boundary of the LA. Thalamic afferents were stimulated at 0.067 Hz using a concentric bipolar electrode. The baseline amplitudes of the evoked EPSPs were adjusted to 4 to 7 mV. LTP was induced with 6 trains of 100 stimuli at 100 Hz (15-sec interval) with 100 μM picrotoxin to inhibit GABAergic inputs.
Statistical analysis. Group differences were evaluated using Student's t-test or two-way analyses of variance (ANOVA) followed by Newman-Keuls comparisons. p < 0.05 was considered significant. All statistics are mean ± SEM.
